A new weight-loss jab will be rolled out on the NHS in England - but it could take 12 years for everyone to receive it, the ...

To help the NHS manage demand, the health organisation's spending watchdog said about 220,000 people could benefit from the ...

England’s National Health Service will begin rolling out Eli Lilly & Co.’s blockbuster weight-loss drug Mounjaro over the next few months, though the medication will initially be made available to ...

The “difficult decision” was made “in order to protect other vital NHS services”, the National Institute for Health and Care ...

Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's obesity drug Mounjaro be made available to around 220,000 people in the country via the state health ...

The U.K. will soon offer Eli Lilly's Mounjaro for people with obesity — but only to a small share of those medically eligible ...

NICE has recommended Eli Lilly's obesity drug Mounjaro for around 220,000 people in the UK via the state health system over ...

The NHS spending watchdog has recommended Mounjaro – also known as tirzepatide and made by Eli Lilly – for those with a body ...

Following its endorsement of Eli Lilly’s obesity medicine tirzepatide, England’s National Institute for Health and Care ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than ...